The role of surgery for high-risk prostate cancer

被引：0

作者：

Ucer, Oktay ^{[1
]}

Muezzinoglu, Talha ^{[1
]}

机构：

[1] Celal Bayar Univ, Tip Fak, Urol Anabilim Dali, Manisa, Turkey

来源：

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2014年 / 13卷 / 01期

关键词：

high-risk prostate cancer; radical prostatectomy; prostate cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Because of PSA screening, urologists can detect clinically localized prostate cancer in patients before the disease has progressed to advanced stages. Nevertheless, some patients are still diagnosed with high-risk prostate cancer. Surgery for high-risk prostate cancer is applied frequently nowadays. Nevertheless, this approach is still surrounded by many controversies. In some high-risk prostate cancer patients, surgery is a one-step modality in treatment and has an excellent oncological prognosis. However, because of the lack of evidence and well-controlled comparative prospective studies, the best course of treatment can be unclear, and oncological outcomes often appear heterogeneous. The aim of this review is to discuss the role of surgery in high risk prostate cancer.

引用

页码：21 / 24

页数：4

共 50 条

[31] The role of radical prostatectomy as an initial approach for the treatment of high-risk prostate cancer
Jaunarena, J. H.
Villamil, W.
Martinez, P. F.
Gueglio, G.
Giudice, C. R.
ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (06): : 353 - 360
[32] Role of radical prostatectomy in the treatment of high-risk prostate cancer
Yossepowitch O.
Eastham J.A.
Current Urology Reports, 2008, 9 (3) : 203 - 210
[33] High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation
Molitoris, Jason K.
Alexander, Gregory S.
Siddiqui, Osman
Cohen, Justin
Mishra, Mark, V
Rana, Zaker
CURRENT OPINION IN ONCOLOGY, 2021, 33 (03) : 238 - 243
[34] The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer
Harbin, Andrew C.
Eun, Daniel D.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (05) : 208 - 216
[35] High-risk localized prostate cancer: role of radical prostatectomy
Grubb, Robert L.
Kibel, Adam S.
CURRENT OPINION IN UROLOGY, 2010, 20 (03) : 204 - 210
[36] Current Status of Neoadjuvant Treatment Before Surgery in High-Risk Localized Prostate Cancer
Rivas, Juan Gomez
Polledo, Luis Enrique Ortega
Sanchez, Irene de la Parra
Hidalgo, Beatriz Gutierrez
Monterrubio, Javier Martin
alvarez, Maria Jesus Marugan
Somani, Bhaskar K.
Enikeev, Dmitry
Vazquez, Javier Puente
Salgado, Noelia Sanmamed
Romo, Maria Isabel Galante
Sierra, Jesus Moreno
CANCERS, 2025, 17 (01)
[37] Metformin and statins: a possible role in high-risk prostate cancer
Cadeddu, Giovanna
Hervas-Moron, Asuncion
Martin-Martin, Margarita
Pelari-Mici, Lira
Ytuza-Charahua de Kirsch, Kathy
Hernandez-Corrales, Antonio
Vallejo-Ocana, Carmen
Sastre-Gallego, Sara
Carrasco-Esteban, Eliseo
Sancho-Garcia, Sonsoles
Lopez-Campos, Fernando
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (02) : 163 - 167
[38] ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer
McLaughlin, Patrick W.
Liss, Adam L.
Nguyen, Paul L.
Assimas, Dean G.
D'Amico, Anthony V.
Gottschalk, Alexander R.
Gustafson, Gary S.
Keol, Sameer R.
Liauw, Stanley L.
Lloyd, Shane
Movsas, Benjamin
Prestidg, Bradley R.
Showalter, Timothy N.
Taira, Al V.
Vapiwal, Neha
Davi, Brian J.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (01): : 1 - 10
[39] Evolving role of surgery, radiation, hormone therapy, and chemotherapy in high-risk locally advanced prostate cancer
Mannuel, Heather D.
Hussain, Arif
CLINICAL GENITOURINARY CANCER, 2006, 5 (01) : 43 - 49
[40] Advances in the Multimodality Management of High-risk Prostate Cancer
Garzotto, Mark
Hung, Arthur Y.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 22 (02) : 375 - +

← 1 2 3 4 5 →